COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
6.58
-0.20 (-2.95%)
At close: Mar 6, 2026, 4:00 PM EST
6.75
+0.17 (2.58%)
After-hours: Mar 6, 2026, 7:47 PM EST
COMPASS Pathways Employees
COMPASS Pathways had 166 employees as of December 31, 2024. The number of employees decreased by 20 or -10.75% compared to the previous year.
Employees
166
Change (1Y)
-20
Growth (1Y)
-10.75%
Revenue / Employee
n/a
Profits / Employee
-$1,429,614
Market Cap
746.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 166 | -20 | -10.75% |
| Dec 31, 2023 | 186 | 5 | 2.76% |
| Dec 31, 2022 | 181 | 65 | 56.03% |
| Dec 31, 2021 | 116 | 54 | 87.10% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Community Health Systems | 57,000 |
| Ardent Health | 24,900 |
| Enhabit | 10,700 |
| The Pennant Group | 9,700 |
| U.S. Physical Therapy | 7,028 |
| Sonida Senior Living | 5,063 |
| AMN Healthcare Services | 2,664 |
| InnovAge Holding | 2,440 |
CMPS News
- 8 days ago - Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants - Business Wire
- 10 days ago - Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026 - Business Wire
- 16 days ago - Compass Pathways Announces Pricing of $150 Million Public Offering - Business Wire
- 17 days ago - COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials Transcript - Seeking Alpha
- 17 days ago - Compass Pathways Launches Proposed $150.0 Million Public Offering - Business Wire
- 17 days ago - Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot - Seeking Alpha
- 17 days ago - Compass Pathways' depression treatment meets main goal in late‑stage study - Reuters
- 17 days ago - Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression - Business Wire